(Total Views: 356)
Posted On: 08/02/2019 10:55:40 AM
Post# of 132

$JAGX News Article - Jaguar Health's CDMO Improves Manufacturing Processes to Support the Expanded Crofelemer Manufacturing Volume Expected to be Required for Potential Expanded Indications, Including a Potential Indication for Cancer Therapy-related Diarrhea https://marketwirenews.com/news-releases/jagu...94112.html


My Twitter: WhyteStocks